Strengthening cancer control through strategic partnerships

Purposeful partnerships with trusted partners are critical to delivering UICC’s ambitious plans. Despite the challenges of 2020, UICC successfully delivered high-impact activities and managed to unite and support the global cancer community throughout the pandemic.

Partners reacted positively to UICC’s new approach during the pandemic and offered expertise, knowledge, and financial support, enabling members to stay connected, exchange knowledge, access expert insights and share solutions on a series of topics of interest. This enabled the community to use its collective voice to mobilise global engagement on cancer control, identify solutions and heighten impact. The flexibility of UICC partners and their additional support and commitment during 2020 was invaluable. UICC expresses its sincere appreciation to all partners, highlighting specifically the BMS and Pfizer foundations as well as Fondation Philanthropia, who provided additional funding to help UICC navigate the crisis and transition its activities.

The current portfolio of partnerships includes UN agencies, the City Cancer Challenge Foundation, the NCD Alliance and the McCabe Centre for Law & Cancer, as well as foundations and private companies from different sectors.

Examples of UICC’s committed partners include MSD, Novartis, Pfizer and the Canadian Partnership Against Cancer, who supported the Virtual Dialogues on “Cancer beyond COVID-19”. This series explored what the health landscape might look like post-pandemic and opportunities to shape better cancer care going forward. Sanofi supported UICC’s critical work on equity and ageing, including a series of three dialogues on cancer and ageing.